Early Radiation Dermatitis Clinical Trial
Official title:
Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients Receiving Radiation Therapy
Radiation dermatitis is an acute effect of radiation therapy,Especially in the neck skin of head and neck squamous cell carcinomas' patients.The investigators wanted to confirm the benefit of mometasone furoate (MF) in preventing acute radiation reactions, as shown in a previous study.
A randomized,self-comparative controlled trial was undertaken comparing MF cream with no
cream administered from the first day of treatment for 5-6 weeks to prevent radiation
dermatitis of neck during radiation therapy to the head and neck squamous cell carcinomas'
Patients.
One side of patients' neck will begin to use MF cream from the first day of radiation
therapy, while the other side accept no preventive measures.
;
Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research